Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).

Biotechnology

Gyroscope Therapeutics

Gyroscope Therapeutics' headquarters in London, United Kingdom

Khurem Farooq

Jane Hughes

Elaine Johnston

Ingrid Boyes

Jessica Stitt

Ian Pitfield

Edward Lang Jr

Nadia Waheed

Keith Peters

Alberto Auricchio

Pete Coffey

Robert Maclaren

Matthew Pickering

David Steel

Timothy Stout

Jacque Duncan

Jeffrey S. Heier

Allen C. Ho

Hendrik P.N. Scholl

Sean Bohen

Arshad M. Khanani

Chris Hollowood

Ian Clark

Claire Harris

Jean Bennett

David Kavanagh

Bernhard H.F. Weber

Charles C. Wykoff

The Clinical and Scientific Operations team at Gyroscope Therapeutics is responsible for overseeing the design and execution of clinical trials related to retinal gene therapies. This multidisciplinary team collaborates closely with scientific and clinical advisory board members, researchers, and operational experts to ensure robust protocol development, regulatory compliance, and quality control in the advancement of innovative treatments for dry age-related macular degeneration. Their work is crucial in bridging laboratory research with clinical application, ultimately aiming to improve patient outcomes in vision health.

Clinical and Scientific Operations

The Leadership Team at Gyroscope Therapeutics is responsible for guiding the strategic direction of the company, overseeing clinical development, technical operations, and business strategies. They collaborate to drive innovation in retinal gene therapy, ensure operational efficiency, manage financial health, and foster a culture of talent and scientific excellence, all aimed at advancing treatments for diseases like dry AMD.

Leadership Team

The Research and Development team at Gyroscope Therapeutics focuses on advancing innovative gene therapies aimed at treating dry age-related macular degeneration and other retinal diseases. Comprising experts in biology, translational research, and analytical development, the team collaborates to design, develop, and optimize therapies, ensuring robust preclinical and clinical validation to bring effective treatments to patients.

Research and Development

This department oversees the strategic direction and organizational leadership through board members.

Executive Governance

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department focuses on ensuring the quality and efficacy of clinical programs, managing clinical processes, and maintaining compliance with regulatory standards.

Quality Assurance and Clinical Operations

Gyroscope Therapeutics

Org chart

Board & advisors

Teams

Clinical and Scientific Operations

Leadership Team

Research and Development

Executive Governance

Executive Leadership

Quality Assurance and Clinical Operations

Offices

Gyroscope Therapeutics

Org chart

Board & advisors

Teams

Clinical and Scientific Operations

Leadership Team

Research and Development

Executive Governance

Executive Leadership

Quality Assurance and Clinical Operations

Offices

Related companies